Literature DB >> 25192482

Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.

Joshua W Gatson1, Jennifer Barillas, Linda S Hynan, Ramon Diaz-Arrastia, Steven E Wolf, Joseph P Minei.   

Abstract

OBJECT: In previous studies of traumatic brain injury (TBI), neural biomarkers of injury correlate with injury severity and predict neurological outcome. The object of this paper was to characterize neurofilament-H (NFL-H) as a predictor of injury severity in patients who have suffered mild TBI (mTBI). Thus, the authors hypothesized that phosphorylated NFL-H (pNFL-H) levels are higher in mTBI patients than in healthy controls and identify which subjects experienced a more severe injury such as skull fractures, intracranial hemorrhaging, and/or contusions as detected by CT scans.
METHODS: In this prospective clinical study, blood (8 ml) was collected from subjects (n = 34) suffering from mTBI (as defined by the American Congress of Rehabilitation and Glasgow Coma Scale scores between 13 and 15) at Parkland Hospital, Dallas, Texas, on Days 1 and 3 after injury). Additional clinical findings from the CT scans were also used to categorize the TBI patients into those with and those without clinical findings on the scans (CT+ and CTgroups, respectively). The serum levels of pNFL-H were measured using the enzyme-linked immunosorbent assay.
RESULTS: Compared with healthy controls, the mTBI patients exhibited a significant increase in the serum levels of pNFL-H on Days 1 (p = 0.00001) and 3 (p = 0.0001) after TBI. An inverse correlation was observed between pNFL-H serum levels and Glasgow Coma Scale scores, which was significant. Additionally, using receiver operating characteristic curve analysis to compare the mTBI cases with controls to determine sensitivity and specificity, an area under the curve of 100% was achieved for both (p = 0.0001 for both). pNFL-H serum levels were only significantly higher on Day 1 in mTBI patients in the CT+ group (p < 0.008) compared with the CT- group. The area under the curve (82.5%) for the CT+ group versus the CT- group was significant (p = 0.021) with a sensitivity of 87.5% and a specificity of 70%, using a cutoff of 1071 pg/ml of pNFL-H in serum.
CONCLUSIONS: This study describes the serum profile of pNFL-H in patients suffering from mTBI with and without CT findings on Days 1 and 3 after injury. These results suggest that detection of pNFL-H may be useful in determining which individuals require CT imaging to assess the severity of their injury.

Entities:  

Keywords:  AUC = area under the curve; ELISA = enzyme-linked immunosorbent assay; GCS = Glasgow Coma Scale; GFAP = glial fibrillary acidic protein; MAMBA = Mild and Moderate TBI Biomarker (study); NFL-H = neurofilament-H; NSE = neuron-specific enolase; ROC = receiver operating characteristic; TBI = traumatic brain injury; mTBI = mild TBI; mild traumatic brain injury; neurofilament-H; pNFLH = phosphorylated NFL-H; serum

Mesh:

Substances:

Year:  2014        PMID: 25192482     DOI: 10.3171/2014.7.JNS132474

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  34 in total

Review 1.  How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury.

Authors:  Denes V Agoston; Robert Vink; Adel Helmy; Mårten Risling; David Nelson; Mayumi Prins
Journal:  J Neurotrauma       Date:  2019-03-07       Impact factor: 5.269

2.  Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.

Authors:  Nils Henninger; James Bouley; Elif M Sikoglu; Jiyan An; Constance M Moore; Jean A King; Robert Bowser; Marc R Freeman; Robert H Brown
Journal:  Brain       Date:  2016-02-11       Impact factor: 13.501

Review 3.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

Review 4.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

Review 5.  Potential Blood-based Biomarkers for Concussion.

Authors:  Linda Papa
Journal:  Sports Med Arthrosc Rev       Date:  2016-09       Impact factor: 1.985

Review 6.  The current state of biomarkers of mild traumatic brain injury.

Authors:  Han Jun Kim; Jack W Tsao; Ansley Grimes Stanfill
Journal:  JCI Insight       Date:  2018-01-11

7.  Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.

Authors:  Tanya Bogoslovsky; David Wilson; Yao Chen; David Hanlon; Jessica Gill; Andreas Jeromin; Linan Song; Carol Moore; Yunhua Gong; Kimbra Kenney; Ramon Diaz-Arrastia
Journal:  J Neurotrauma       Date:  2016-07-08       Impact factor: 5.269

8.  Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.

Authors:  Damon C Barbacci; Aurelie Roux; Ludovic Muller; Shelley N Jackson; Jeremy Post; Kathrine Baldwin; Barry Hoffer; Carey D Balaban; J Albert Schultz; Shawn Gouty; Brian M Cox; Amina S Woods
Journal:  ACS Chem Neurosci       Date:  2017-08-14       Impact factor: 4.418

9.  Early versus Late Profiles of Inflammatory Cytokines after Mild Traumatic Brain Injury and Their Association with Neuropsychological Outcomes.

Authors:  Aditya Vedantam; Jeffrey Brennan; Harvey S Levin; James J McCarthy; Pramod K Dash; John B Redell; Jose-Miguel Yamal; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2020-08-05       Impact factor: 5.269

10.  Coordinating Global Multi-Site Studies of Military-Relevant Traumatic Brain Injury: Opportunities, Challenges, and Harmonization Guidelines.

Authors:  David F Tate; Emily L Dennis; John T Adams; Maheen M Adamson; Heather G Belanger; Erin D Bigler; Heather C Bouchard; Alexandra L Clark; Lisa M Delano-Wood; Seth G Disner; Blessen C Eapen; Carol E Franz; Elbert Geuze; Naomi J Goodrich-Hunsaker; Kihwan Han; Jasmeet P Hayes; Sidney R Hinds; Cooper B Hodges; Elizabeth S Hovenden; Andrei Irimia; Kimbra Kenney; Inga K Koerte; William S Kremen; Harvey S Levin; Hannah M Lindsey; Rajendra A Morey; Mary R Newsome; John Ollinger; Mary Jo Pugh; Randall S Scheibel; Martha E Shenton; Danielle R Sullivan; Brian A Taylor; Maya Troyanskaya; Carmen Velez; Benjamin Sc Wade; Xin Wang; Ashley L Ware; Ross Zafonte; Paul M Thompson; Elisabeth A Wilde
Journal:  Brain Imaging Behav       Date:  2021-01-07       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.